Keywords
MedicineProtein CChemokineInflammationImmunologyPneumoniaApoptosisDownregulation and upregulationBiologyInternal medicine
Affiliated Institutions
Related Publications
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Corticosteroid therapy in patients with MERS was not associated with a difference in mortality after adjustment for time-varying confounders but was associated with delayed MERS...
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
OBJECTIVE: In 2003, critical care and infectious disease experts representing 11 international organizations developed management guidelines for severe sepsis and septic shock t...
Publication Info
- Year
- 2020
- Type
- article
- Volume
- 4
- Issue
- 4
- Pages
- 506-509
- Citations
- 30
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
30
OpenAlex
Cite This
John H. Griffin,
Patrick D. Lyden
(2020).
COVID‐19 hypothesis: Activated protein C for therapy of virus‐induced pathologic thromboinflammation.
Research and Practice in Thrombosis and Haemostasis
, 4
(4)
, 506-509.
https://doi.org/10.1002/rth2.12362
Identifiers
- DOI
- 10.1002/rth2.12362